The recent discovery that mammalian cells" can synthesize nitric oxide coincided with the identification of this simple gas as a factor involved in cellular communication. Nitric • N=O as a metabolite and examine its biochemical synthesis and possible biological function. Another recent review by Moncada and colleagues I emphasizes the regulation of cell function and communication.
Nitric oxide: biosynthesis and biological significance
Michael A. Marietta
The recent discovery that mammalian cells" can synthesize nitric oxide coincided with the identification of this simple gas as a factor involved in cellular communication. Nitric oxide has now been shown to be derived from L-arginine in macrophages, endothelial cells" and possibly other cell types. Its physiological role in macrophages may be as a cytotoxic agent. However, nitric oxide produced by endothelial cells is thought to trigger vascular smooth muscle relaxation through activation of the enzyme guanylate cyclase.
The study of what appeared to be quite diverse physiological reactions led to the discovery of nitric oxide (.N=O) as a mammalian metabolite that plays a critical role in cellular communication as well as other important functions. The investigation of the apparent synthesis of nitrate (NOq) by mammalian cells revealed that, in macrophages,
• N=O was an intermediate in the production of both NO,~ and nitrite (NO~) from L-arginine. In quite unrelated experiments, a factor produced by endothelial cells was shown to be required for the acetylcholine-induced relaxation of vascular smooth muscle. This factor has now been identified as • N=O, also derived from L-arginine. This review will summarize these initial studies that led to the identification of
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• N=O as a metabolite and examine its biochemical synthesis and possible biological function. Another recent review by Moncada and colleagues I emphasizes the regulation of cell function and communication.
It is rare to find such a reactive molecule as a free intermediate in mammalian biochemistry. The chemistry of • N=O has been studied a great deal although not typically under biological conditions. Nitric oxide reacts readily with molecular oxygen in the gas phase and in aqueous solution to yield nitrogen dioxide (NO2) which is also reactive and ultimately reacts to form NO2 and NO3 via the hydrolysis of N203 and N204. The role of .N=O as an enzymebound intermediate in the reduction of NO 2 by anaerobic denitrifying bacteria has been demonstrated by Hollocher and co-workers over the last several years 2, however, as will be described below, the mammalian pathway for • N=O is quite distinct from the bacterial reductive pathway. 
Macrophage synthesis of NO~ and NO~
The first metabolic balance studies consistent with mammalian synthesis of NO~ were carried out at the turn of the century (see Ref. 3 and references therein). Renewed interest in NO,~ synthesis in humans stemmed from the potential for the formation of carcinogenic N-nitrosamines using this metabolically-derived NO`q as a reactant. The endogenous formation of Nnitrosamines has been under investigation for about the last 20 years and the conditions that could lead to the reaction of secondary amines with NO2 have been well studied 3. Previously, exposure to NO,~ was always presumed to be that from environmental sources.
Tannenbaum and co-workers 3 first showed that NO7 synthesis was indeed a mammalian process. They found that humans and rats, when maintained on a low NO3 diet (--180 lamol day -I for humans), excreted levels well above the ingested amount. Similar results were obtained with germ-free rats, thus ruling out the participation of gut microflora in the reaction. During the course of the human experiments, one of the subjects coincidentally became ill and showed a large increase in urinary NO3 excretion. Subsequent experiments in rats showed that the urinary NO3 levels could be elevated about tenfold when fever was induced by an intraperitoneal injection of E. coli lipopolysaccharide (LPS) 3. These findings suggested that this elevated synthesis might be related to the immunostimulation known to be brought about by LPS.
The studies above suggested a poten- Further studies with the RAW 264.7 macrophage cell line showed that the chemical precursor to NO~ and NO~ was exclusively the amino acid L-arginine which was converted to citrulline 7. Experiments carried out with L-[guanidino-15Nz]-arginine unequivocally showed that the nitrogen atoms of both NO2 and NO3 were derived solely from one of the two chemically equivalent ~SN-labeled nitrogens 7. Initially it was assumed that the NO~ resulted from the oxidation of NO2 but experiments suggested that both anions were derived from a common intermediateS; experiments with L-[guanidino-15N2]-arginine showed that .N=O was labeled s'9. The formation of NO2 and NO~ was specific for the L (S) stereochemistry at the a-carbon of arginine 7. Hibbs anet co-workers had been studying the cytostasis in certain tumor target cells induced by co-culture with activated macrophages.
They found that this cytostatic-inducing property required L-arginine in the cell culture medium l°, and they showed, using unlabeled L-arginine, that activated macrophages synthesized N02 and citrulline from L-arginine 11.
Endothelium-derived relaxing factor (EDRF)
In 1980, Furchgott and Zawadzki showed that endothelial cells were required for the acetylcholine-induced relaxation of vascular smooth muscle. A number of substances are now known that lead to the release of endothelium-derived relaxing factor (EDRF), including adenine nucleotides, calcium ionophores and bradykinin. The major pharmacological properties of EDRF are smooth muscle relaxation in a number of different vascular preparations and the inhibition of platelet aggregation ~2, ~3. Speculation about the structure of EDRF continued until 1986 when Furchgott and Ignarro suggested that it might in fact be .N=O. Experiments carried out by Moncada and colleagues 14 showed that EDRF was indeed .N=O. Using a bioassay consisting of a strip of smooth muscle superfused by effluent from a column containing porcine aortic endothelial cells immobilized on microcarriers, they showed that release of EDRF from bradykinin-stimulated cells led to relaxation in the strip of smooth muscle. A number of indirect experiments showed the structure of EDRF was consistent with the chemical properties of .N=O. Then, using chemiluminescence detection, they directly observed the formation of-N = O. This finding has been reproduced now by several laboratories. Moncada and colleagues next showed that the precursor to .N=O was L-arginine ~5, suggesting an identical pathway to that characterized in macrophages. There is some evidence that polybasic polypeptides containing L-arginine can serve as substrates for EDRF generation but it is not clear if these alternate substrates serve simply as metabolic precursors to L-arginine. The identification of .N=O as EDRF suggests a mechanism of action for the vasodilatory drugs such as amyl nitrite and nitroglycerin. Used since the 19th century, these compounds will produce .N=O in the presence of thiols such as glutathione thereby circumventing the generation of .N=O from L-arginine.
Biosynthesis of.N=O

General characteristics
While the pathway itself appears to be identical in macrophages and endothelial cells, its regulation in the two cell types is quite different. In macrophages no enzymatic activity is observed in either freshly isolated, thioglycolate-elicited peritoneal cells or in any of the macrophage cell lines examined without activation by LPS and/or IFN-74-6. A lag phase that is dependent on the concentration of the activating agent(s) is observed during which time protein synthesis required for the expression of the pathway takes place. After the lag phase that is typically about eight hours, the synthesis of NO~ and NO3 begins and continues linearly for about 48 hours after which time cell death leads to a decreased rate of synthesis 6. The similarity of freshly isolated cells and cell lines has been demonstrated and we have made use of cell lines extensively, in particular the RAW 264.7 line that is both quantitatively and qualitatively identical to freshly isolated cells 6. In the cell-free system described below the synthesis of • N=O, and consequently NO2 and NOq, continues as long as the substrates are available s.
The situation in endothelial cells is very different. Protein synthesis is apparently not required. Stimulation by, for example, bradykinin, leads to an immediate burst in .N=O synthesis which decays rapidly 14. When 1-2 × 107 cells were stimulated with bradykinin at 10 min intervals, the amounts produced (< 1 nmoi) are small relative to those produced in the macrophage but nonetheless significant. The rapid decay is due to reaction with 02, leading to production of NO~ and NO3, typically in amounts below the limit of detection. When stimulated with bradykinin at 10 minute intervals, -N=O was released with each treatment, the amount released (between 70 pmol and approximately 0.7 nmol) being dependent on the concentration of bradykinin used 12"14. The calcium ionophore A23187 is the only stimulant that leads to an extended release of . N=O (Ref. 15) ; an immediate increase in .N=O decays slowly over the next 30 minutes. This is presumably due to an extended but decreasing rate of synthesis along with a continual decomposition reaction.
A recent report is consistent with the generation of .N=O in the rat cerebellum after stimulation of N-methyl-D-aspartate receptors I~'. Nitric oxide was not measured directly, but the indirect experiments are all consistent with the chemical properties of .N=O. The burst of .N= O formation is similar to that observed in endothelial cells.
Substrate, products and inhibitors
When activated macrophages were placed in media that lacked all free amino acids, synthesis of NO2 and NO~ was 25-30% of that obtained in the normal media. The only amino acid that restored the synthesis of NO2 and NO? was L-arginine. In fact, L-arginine at 2 mN gave 120% the value obtained with the amino acid complete media that contains 0.6 mM l,-arginine. No other naturally occurring amino acid was shown to be a substrate 5. The background synthesis obtained in the amino acid free medium is probably derived from endogenous arginine, and results with varying concentrations of [15N]-arginine are consistent with this conclusion 7. Studies with 14C-labeled L-arginine showed that citrulline was the other product of the reaction 7 and although the stereochemistry at the {,-carbon was never determined, it has been assumed not to change. No intermediates involving the amino acid backbone were observed. In addition, NH3 and NH2OH were not substrates, ruling out the speculation that the pathway involved hydrolysis of L-arginine to citrulline and NH3 followed by the oxidation of NH3 to NO5 and NO? (Ref. 11). The enzyme catalysing this hydrolysis reaction, arginine deimidase, has never been reported in mammalian tissues. The reaction seems to be quite specific for L-arginine. Equimolar concentrations of L-homoarginine ( Fig. 1) are about 80% as efficient for NO2 and NO~ synthesis 7. I>Argi-nine is not a substrate nor does it inhibit the reaction 7"m either in vivo or in a cell-free system, thus ruling out the possibility of the inability of I)-arginine to enter the cell. Moncada and colleagues have shown that the .N= O produced from endothelial cells is derived from the same guanidino nitrogens of >-arginine 15 . These experiments again utilized
L-[guanidino-15N2] -
arginine with bradykinin stimulation. A limited number of compounds have been studied as potential inhibitors of this reaction. Hibbs and coworkers were the first to show that a monomethylated arginine analogue, NC-monomethyl-L-arginine (Fig. 1) inhibited NO2 formation in macrophages 11 . The inhibition in the cell free activity from macrophages was 50% at 130 laM (Ref. 8) . This compound was shown to have a similar inhibitory effect in endothelial cells is. In contrast, I,-canavanine, a fairly broad inhibitor of arginine-utilizing reactions, inhibits NO2 and NO3 synthesis in macrophages 7 but has no effect on the reaction in endothelial cell cultures 15 or homogenates ~7. Thus, although the pathway of .N=O formation in the two cell types seems to be identical there may be subtle differences in the enzymes involved. The major difference between the two cell types seems to be in the regulation of the biosynthetic pathway, which may be related to physiological function.
Current status of the enzymology
Although some progress has been made, the molecular mechanisms of this unusual oxidation of arginine remain largely unknown. The enzyme activity in macrophages and endothelial cells is found in the cytosolS'~7; activity was recovered exclusively in the 100 000 g supernatant in subcellular fractionation experiments. In addition, reducing equivalents are required in broken cell preparations. NADPH, but not NADH or ascorbic acid, will support the oxidation of arginine to citrulline and .N=O with subsequent decomposition of the -N=O to NO7 and NO~ (Ref. 8) . Supernatant from non-activated RAW 264.7 cells was completely inactive. The activity in endothelial cell 100 000 g supernatant also required NADPH and was inhibited by NC-monomethyl-Larginine 17.
All the evidence suggested that the first step of the reaction pathway was the hydroxylation of arginine at one of two equivalent guanidino nitrogens forming NC-hydroxy-L-arginine (Fig.  1) . A synthetic version of this compound (Nanjappan, Woodard and Marietta, unpublished), has been shown to be a substrate for the reaction leading to NO2, NO? and citrulline in a cell-flee system (Pufahl, Tayeh, Nanjappan, Woodard and Marietta, unpublished). The reaction also required NADPH.
NG-Hydroxy-L-homoarginine was also synthesized and found to be a substrate.
A proposed scheme that is consistent with all the evidence obtained to date is shown in Fig. 2 (Ref. 8) . The first step illustrates the hydroxylation of arginine yielding N%hydroxy-t-arginine. Although steps 2-5 are speculative, they do provide a chemically reasonable pathway to give the final products of the reaction, citrulline, NO2 and NO3.
Step 2 simply shows a twoelectron oxidation of the hydroxylamine moiety, a common reaction for this relatively unstable functional group, producing N%oxo-L-arginine. The electron acceptor in this reaction is presently unknown. This product could also be formed by a second hydroxylation upon N%hydroxy-e-arginine followed by a dehydration. This would explain the need for additional NADPH when N~-hydroxy-L-arginine is used as a substrate. The attractive feature of the third step is that, by simple loss of a hydrogen atom, the amino acid radical generated would be expected to be very unstable and should fragment as indicated in step 4 to yield .N=O and an amino acid carbodiimide. This compound, N-[(2-amino)-valeryl]-carbodiimide, would be expected to react with H20 in a manner typical of carbodiimides to yield, in this particular case, citrulline.
Early efforts directed toward the purification of the enzyme(s) involved in this reaction pathway were hampered by the apparent instability of the activity. A series of experiments showed that this loss of activity was not due to enzyme instability, but to the loss of a low molecular weight cofactor, recently shown to be tetrahydrobiopterin ~s. Arginine loss and product formation are dependent on tetrahydrobiopterin. The other three mammalian tetrahydrobiopterin-requiring hydroxylases (phenylalanine-, tyrosine-and tryptophan-hydroxylase) all carry out reactions at aromatic carbons and so these results suggest a novel hydroxylation for tetra-hydrobiopterin at a guanidino nitrogen.
Biological function of nitric oxide generation
The proposals regarding the biological role for -N=O have mainly centered around the enzyme guanylate cyclase. This enzyme catalyses the conversion of GTP to cyclic GMP (cGMP). It had been known for some time., that .N=O was capable of activating guanylate cyclase leading to a substantial increase in cGMP levels a9. Other compounds that activate guanylate cyclase include NAN3, NH2OH, NaNO2, nitroglycerin and sodium nitroprusside. Under biological conditions all these agents are capable of generating .N=O. The enzyme is ubiquitous and exists in both soluble and particulate (membrane bound) forms. Both forms are generally found in the same cell, although the amounts and subcellular localization vary from cell to cell and are influenced by the particular physiological state of the cell. The soluble enzyme has been purified to homogeneity from a number of sources and, consequently, has received more attention than the particulate form. The purified soluble enzyme will bind a hem.s prosthetic group and the reaction of .N=O with iron proteins, particularly hemoproteins, is well known 2°. Evidence suggests that binding of .N=O to the heme plays a direct role in the activation of the enzyme. The key experiments supporting the .N=O-heme interaction model have come from a number of laboratories and show that some purification procedures can lead to the loss of the prosthetis heme with resulting loss in the ability to be activated by .N=O and related agents. However, reconstitution ef the hemedepleted enzyme with hematin and reducing agents, typically thiols, leads to enzyme that can once again be stimulated by .N=O generating compounds 19. The amount of activation is dependent on the source of the enzyme and ranges from 10-to 50-fi)ld. It is also clear that activation of guanylate cyclase involves thiols on the enzyme and the evidence taken together suggests oxidation/reduction processes that are linked to the basal and activated activity of the enzyme. Guanylate cyclase shows high-affi nity binding for heme 2l, and studies concerning the physiological importance of this are continuing.
The role of cGMP as a second messenger is not as well developed as that for another cyclic nucleotide, cAMP. However, over the last 5-10 years cGMP has assumed a more prominent role as second messenger, in particular, increases in cGMP have been associated with smooth muscle relaxation. Alterations in Ca 2+ levels induced by cGMP ultimately control smooth muscle tension. Several laboratories 
H3N~COO -
showed that the nitrovasodilators, such as nitroglycerin, produce an increase in cGMP levels in smooth muscle tissue and, as mentioned above, these nitrovasodilators can activate the enzyme guanylate cyclase through the generation of .N=O. Thus, nitrovasodilators might simply circumvent the generation of .N=O from arginine and produce • N=O directly. Taken together, these findings suggest that at least one physiological role of the arginine pathway is to activate guanylate cyclase leading to an increase in the second messenger cGMP. Other recent results support this proposed role including those of Garthwaite and colleagues 16 who showed that glutamate induced the release of a diffusible messenger that had chemical properties very similar to .N=O. This appears to be another example of intercellular communication where the intracellular signal is cGMP whose level is increased via the activation by .N=O. It has long been known that in the central nervous system, and especially in the cerebellum, the excitatory neurotransmitter glutamate can elicit large increases in cGMP levels. What, then, is the role of .N=O production in the macrophage? There are two major possibilities. The killing and cytostasis-inducing functions of activated macrophages might suggest that, through its chemical properties, .N=O is acting as a cytotoxic agent. Hibbs and colleagues have reported that L-arginine is required for activated macrophages to induce cytostasis in target tumor cell lines 1°. Furthermore, they have recently reported 9 that the same pattern of metabolic inhibition induced by macrophages in the tumor cell line can be reproduced directly by .N--O. On the other hand, it is known that cyclic nucleotides are involved in the regulation of several macrophage functions including phagocytosis, motility, response to lymphokines and DNA synthesis and it has been reported that macrophages treated with -N=O generating agents show a large increase in cGMP levels 22. This would suggest that macrophage killing/cytostatic properties might be cGMP dependent and that the .N=O synthesized is used to elevate intracellular cGMP levels.
The involvement of .N=O as a key metabolite in the activation of the enzyme guanylate cyclase represents a novel control mechanism. The biochemistry of the pathway of.N = O production including the oxidation of e-arginine at the guanidino nitrogen will no doubt involve some novel enzymology that has already begun to unfold. The understanding of this enzymology and regulation of this pathway will ultimately lead to agents specifically designed for the rational control of -N=O formation. The pharmacological potential for these new agents is promising. also reaches the liver as haptoglobinhaemoglobin and haem-haemopexin complexes, arising out of intravascular hemolysis of senescent red cells. Uptake by the liver is mediated by specific receptors. There is evidence that haem from haem-haemopexin reaches several target sites including the liver nucleus 3. It is not clear whether the newly biosynthesized haem mixes with the haem derived from red cells or whether separate pools are maintained. However, it appears that both should be contributing to the regulatory pool, since haemregulated proteins are responsive to haem levels generated in the mitochondrion as well as to exogenous haem.
Haem regulates its own biosynthesis
The two crucial enzymes involved in regulating the levels of intracellular haem in liver are ALA synthetase (ALAS) and haem oxygenase I. ALAS is induced by a wide variety of chemicals and suppressed by the administration of haem. There is good evidence that haem negatively regulates the synthesis of ALAS 4. With the use of cloned cDNA, it has been shown in rat liver that haemin (the oxidized form of haem), actinomycin D and ct-amanatin bring about a rapid decrease in the intracellular levels of ALAS mRNA, pre-induced by 2-ailylisopropylacetamide. Since there is no change in the half-life of ALAS mRNA under these conditions, haemin most likely represses the transcription of the gene 5. Earlier, this laboratory had proposed a positive regulatory model, where ALAS induction could be positively modulated by apo-cytochromc P-450, the effect ceasing with thc formation of the holoprotein 6. Haem
